Search for a trial

LANDMARK Trial: A prospective, multinational, multicentre, open-label, randomised, noninferiority
trial to compare safety and effectiveness of Meril*s Myval Transcatheter Heart Valve
(THV) series vs. Contemporary Valves (Edwards* Sapien THV series and Medtronic*s Evolut
THV series) in patients with severe symptomatic native aortic valve stenosis.

LANDMARK Trial is designed to compare safety and effectiveness of Meril*s Myval Transcatheter Heart Valve (THV) series vs. Contemporary Valves (Edwards* Sapien THV series and Medtronic*s Evolut THV series) in patients with severe symptomatic native…